Novo Nordisk Stock Challenges - Search News

News

Novo Nordisk ousts CEO

The Wall Street Journal on MSN · 4d

Ozempic Drugmaker’s CEO Pushed Out Amid Weight-Loss Market Challenges

Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to support a smooth transition to new leadership.

The Times of India on MSN · 4d

Novo Nordisk CEO to step down amid market challenges and stock plunge

Novo Nordisk's CEO, Lars Fruergaard Jorgensen, will step down amidst market challenges and a significant stock price drop, exceeding 50% since June 2024. Increased competition from compounded versions of Ozempic and Wegovy,

Investopedia on MSN · 5d

Novo Nordisk Stock Falls on Surprise CEO Departure

U.S.-listed shares of Novo Nordisk declined in the opening minutes of trading Friday on the surprise news that CEO Lars Fruergaard Jørgensen is stepping down from the Danish drugmaker.

22hon MSN

Novo Nordisk Woes Just Hit Denmark’s Economy. The Stock Is Rising.

That’s a bit harsh given Denmark’s strong growth compared with neighboring countries over the past few years has been largely ...

4don MSN

Why Novo Nordisk Stock Just Slipped

Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results